Mycoplasma Testing Market Trends 2025–2029: Forecasts for Key Growth Segments

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

By How Much Is The Mycoplasma Testing Market Expected To Expand Between 2025 And 2029?

The mycoplasma testing market size has seen rapid growth recently. It is anticipated to increase from $1.08 billion in 2024 to $1.23 billion in 2025, with a compound annual growth rate (CAGR) of 13.3%. This historical growth can be attributed to outbreaks and contamination incidents, heightened awareness, the expansion of the biotechnology sector, research and development initiatives, ongoing healthcare industry trends, and an uptick in cell culture production.

The mycoplasma testing market is anticipated to experience substantial expansion in the coming years. Its size is projected to reach $1.9 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 11.6%. This projected increase over the forecast period stems from factors such as the increasing need for quality assurance, demand from developing markets, the expansion of the biopharmaceutical sector, the surge in cell-based therapies, and the growth of the biotechnology industry. Key trends expected during this period involve adherence to regulatory standards, increased healthcare awareness and diagnostic efforts, readiness for global pandemics, advancements in point-of-care testing, and deeper market presence in evolving economies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=4103&type=smp

Which Factors And Drivers Are Influencing The Mycoplasma Testing Market In 2025?

The rising occurrence of mycoplasma pneumonia is anticipated to stimulate expansion within the mycoplasma testing market in the future. Mycoplasma pneumonia is defined as a respiratory illness resulting from the bacterium Mycoplasma pneumoniae. Essential for diagnosing Mycoplasma pneumonia, mycoplasma testing works by identifying Mycoplasma pneumoniae bacteria within respiratory samples, thereby assisting in prompt and precise detection of the infection for suitable medical care and oversight. As an illustration, the Centers for Disease Control and Prevention, a US-based government entity, reported in December 2023 that approximately 2 million Mycoplasma pneumoniae infections are recorded annually in the United States. Consequently, the growing frequency of mycoplasma pneumonia is propelling the expansion of the mycoplasma testing market.

What Are The Primary Types Of Segments Analyzed In The Mycoplasma Testing Market?

The mycoplasma testingmarket covered in this report is segmented –

1) By Product: Instruments; Assay, Kits, and Reagents

2) By Technology: PCR; ELISA; Enzymatic Methods; DNA Staining; Other Technologies

3) By Application: Cell line Testing; Virus Testing; End- of- Production Cell Testing

4) By End User: Pharmaceutical & Biotechnology Companies; Cell Banks & Laboratories; Contract Research Organizations; Academic Research Institutes

Subsegments:

1) By Instruments: Mycoplasma Detection Systems; Automated Test Equipment; PCR Equipment

2) By Assay: Mycoplasma Assays (PCR-Based, Culture-Based); Qualitative Assays; Quantitative Assays

3) By Kits: Mycoplasma Detection Kits; Mycoplasma Testing Kits for Cell Cultures; Sample Preparation Kits

4) By Reagents: Nucleic Acid Reagents; Cell Culture Reagents; Staining Reagents

What Long-Term Trends Will Shape The Future Growth Of The Mycoplasma Testing Industry?

Leading entities within the market are engaging in various strategic investments, such as introducing innovative offerings, making strides in research and development, and implementing technological advancements, all of which are garnering considerable interest in the mycoplasma testing market. Businesses are releasing novel, innovative products to cater to end-user needs and enlarge their customer base, crucial for sustaining themselves in the competitive commercial environment. For example, in October 2022, SwiftDx, a UK-based biotechnology company, introduced a new test for detecting mycoplasma contamination that employs a PCR-based technique. The SwiftDx Mycoplasma Detection Kit operates as a lateral flow test, offering a swift and precise method for mycoplasma identification. The test requires a small sample taken directly from the cell culture media supernatant, without impeding cell growth. Results are presented in a clear and easily understandable format. This test exhibits high sensitivity and specificity, boasting a detection limit of less than 10 cfu/mL after day 3 of culture.

Who Are The Prominent Global Companies Shaping The Mycoplasma Testing Market?

Major companies operating in the mycoplasma testing market include Abbott Laboratories, Merck KGaA, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Lonza Group AG, Roche Diagnostics International AG, Charles River Laboratories International Inc., Nelson Laboratories Fairfield Inc., Creative Bioarray, Biological Industries Israel Beit Haemek Ltd., Biotools B & M Labs S.A, PromoCell GmbH, American Type Culture Collection, Bionique Testing Laboratories Inc., InvivoGen, Clongen Laboratories LLC, Norgen Biotek Corporation, Gen Bio Sciences (P) Ltd., GeneCopoeia Inc., Minerva Biolabs GmbH, Mycoplasma Experience, Savyon Diagnostics, ScienCell Research Laboratories Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/mycoplasma-testing-global-market-report

Which Region Shows The Highest Potential For Future Expansion In The Mycoplasma Testing Market?

North America was the largest region in the mycoplasma testing market in 2024. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the mycoplasma testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Mycoplasma Testing Market Report:

https://www.thebusinessresearchcompany.com/customise?id=4103&type=smp

Browse Through More Reports Similar to the Global Mycoplasma Testing Market 2025, By The Business Research Company

Healthcare Analytical Testing Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

Automotive Testing Inspection And Certification Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/automotive-testing-inspection-and-certification-global-market-report

Cold Plasma Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cold-plasma-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795